KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Delek US Holdings (DK) EBT (2016 - 2025)

Delek US Holdings has reported EBT over the past 10 years, most recently at $102.3 million for Q4 2025.

  • Quarterly results put EBT at $102.3 million for Q4 2025, up 122.62% from a year ago — trailing twelve months through Dec 2025 was $38.9 million (up 105.51% YoY), and the annual figure for FY2025 was $38.9 million, up 105.51%.
  • EBT for Q4 2025 was $102.3 million at Delek US Holdings, down from $235.0 million in the prior quarter.
  • Over the last five years, EBT for DK hit a ceiling of $469.0 million in Q2 2022 and a floor of -$452.3 million in Q4 2024.
  • Median EBT over the past 5 years was -$22.1 million (2021), compared with a mean of -$22.5 million.
  • Peak annual rise in EBT hit 663.03% in 2022, while the deepest fall reached 2195.06% in 2022.
  • Delek US Holdings' EBT stood at -$8.1 million in 2021, then plummeted by 2195.06% to -$185.9 million in 2022, then dropped by 10.06% to -$204.6 million in 2023, then crashed by 121.07% to -$452.3 million in 2024, then surged by 122.62% to $102.3 million in 2025.
  • The last three reported values for EBT were $102.3 million (Q4 2025), $235.0 million (Q3 2025), and -$103.4 million (Q2 2025) per Business Quant data.